메뉴 건너뛰기




Volumn 49, Issue 10, 2007, Pages 1079-1085

Assessing the safety of anthrax immunization in US Army aircrew members via physical examination

Author keywords

[No Author keywords available]

Indexed keywords

ANTHRAX VACCINE;

EID: 37349108157     PISSN: 10762752     EISSN: None     Source Type: Journal    
DOI: 10.1097/JOM.0b013e318157d305     Document Type: Article
Times cited : (8)

References (32)
  • 3
    • 0036569530 scopus 로고    scopus 로고
    • Working group on civilian biodefense. Anthrax as a biological weapon, 2002: Updated recommendations for management
    • Inglesby TV, O'Toole T, Henderson DA, et al. Working group on civilian biodefense. Anthrax as a biological weapon, 2002: updated recommendations for management. JAMA. 2002;287:2236-2252.
    • (2002) JAMA , vol.287 , pp. 2236-2252
    • Inglesby, T.V.1    O'Toole, T.2    Henderson, D.A.3
  • 4
    • 0034672416 scopus 로고    scopus 로고
    • Use of anthrax vaccine in the United States
    • Advisory Committee on Immunization Practices, RR-15:1-20
    • Advisory Committee on Immunization Practices. Use of anthrax vaccine in the United States. Morbid Mortal Wkly Rep. 2000;49(RR-15):1-20.
    • (2000) Morbid Mortal Wkly Rep , pp. 49
  • 5
    • 37349108460 scopus 로고    scopus 로고
    • Centers for Disease Control and Prevention, Anthrax. Available at, Accessed July 18, 2006
    • Centers for Disease Control and Prevention - Anthrax. Available at http://www.cdc.gov/ncidod/dbmd/diseaseinfo/anthrax_g.htm. Accessed July 18, 2006.
  • 7
    • 0028159234 scopus 로고
    • The Sverdlovsk anthrax outbreak of 1979
    • Meselson M, Guillemin J, Hugh-Jones M, et al. The Sverdlovsk anthrax outbreak of 1979. Science. 1994;266:1202-1208.
    • (1994) Science , vol.266 , pp. 1202-1208
    • Meselson, M.1    Guillemin, J.2    Hugh-Jones, M.3
  • 8
    • 0034056776 scopus 로고    scopus 로고
    • Protecting the health of US military forces: A national obligation
    • Mazzuchi JF, Claypool RG, Hyams KC, et al. Protecting the health of US military forces: a national obligation. Aviat Space Environ Med. 2000;71:260-265.
    • (2000) Aviat Space Environ Med , vol.71 , pp. 260-265
    • Mazzuchi, J.F.1    Claypool, R.G.2    Hyams, K.C.3
  • 10
    • 0036775222 scopus 로고    scopus 로고
    • National Anthrax Epidemiologic Investigation Team. Investigation of bioterrorism-related anthrax, United States, 2001: Epidemiologic findings
    • Jernigan DB, Raghunathan PL, Bell BP, et al. National Anthrax Epidemiologic Investigation Team. Investigation of bioterrorism-related anthrax, United States, 2001: epidemiologic findings. Emerg Infect Dis. 2002;8:1019-1028.
    • (2002) Emerg Infect Dis , vol.8 , pp. 1019-1028
    • Jernigan, D.B.1    Raghunathan, P.L.2    Bell, B.P.3
  • 11
    • 0003597399 scopus 로고    scopus 로고
    • Joellenbeck LM, Zwanziger L, Durch JS, Strom BL, eds, Washington, DC: National Academy Press, Available at
    • Joellenbeck LM, Zwanziger L, Durch JS, Strom BL, eds. The Anthrax Vaccine: Is it Safe? Does it Work? Washington, DC: National Academy Press, 2002. Available at www.nap.edu/catalog/10310.html.
    • (2002) The Anthrax Vaccine: Is it Safe? Does it Work
  • 12
    • 37349047722 scopus 로고    scopus 로고
    • Food & Drug Administration. Biological products; bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order. Fed Reg 2005;70:75180-98. Available at www.fda.gov/cber/rules/ bvactoxanth.pdf http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket. access.gpo.gov/2005/pdf/05-24223.pdf. Accessed February 4, 2006.
    • Food & Drug Administration. Biological products; bacterial vaccines and toxoids; implementation of efficacy review; anthrax vaccine adsorbed; final order. Fed Reg 2005;70:75180-98. Available at www.fda.gov/cber/rules/ bvactoxanth.pdf http://a257.g.akamaitech.net/7/257/2422/01jan20051800/edocket. access.gpo.gov/2005/pdf/05-24223.pdf. Accessed February 4, 2006.
  • 14
    • 0036200947 scopus 로고    scopus 로고
    • Ambulatory medical visits among anthrax vaccinated and unvaccinated personnel after return from southwest Asia
    • Rehme PA, Williams R, Grabenstein JD. Ambulatory medical visits among anthrax vaccinated and unvaccinated personnel after return from southwest Asia. Mil Med. 2002;167:205-210.
    • (2002) Mil Med , vol.167 , pp. 205-210
    • Rehme, P.A.1    Williams, R.2    Grabenstein, J.D.3
  • 15
    • 0037343678 scopus 로고    scopus 로고
    • Analysis of adverse events after anthrax vaccination in U.S. Army medical personnel
    • Wasserman GM, Grabenstein JD, Pittman PR, et al. Analysis of adverse events after anthrax vaccination in U.S. Army medical personnel. J Occup Environ Med. 2003;45:222-233.
    • (2003) J Occup Environ Med , vol.45 , pp. 222-233
    • Wasserman, G.M.1    Grabenstein, J.D.2    Pittman, P.R.3
  • 16
    • 0346817399 scopus 로고    scopus 로고
    • Using a structured medical note for determining the safety profile of anthrax vaccine for U.S. Soldiers in Korea
    • Hoffman K, Costello C, Menich M, Grabenstein JD, Engler RJM. Using a structured medical note for determining the safety profile of anthrax vaccine for U.S. Soldiers in Korea. Vaccine. 2003;21:4399-409.
    • (2003) Vaccine , vol.21 , pp. 4399-4409
    • Hoffman, K.1    Costello, C.2    Menich, M.3    Grabenstein, J.D.4    Engler, R.J.M.5
  • 17
    • 16544377023 scopus 로고    scopus 로고
    • Health effects of anthrax vaccination in the Canadian Forces
    • Hunter D, Zoutman D, Whitehead J, Hutchings J. Health effects of anthrax vaccination in the Canadian Forces. Mil Med. 2004;169:833-838.
    • (2004) Mil Med , vol.169 , pp. 833-838
    • Hunter, D.1    Zoutman, D.2    Whitehead, J.3    Hutchings, J.4
  • 18
    • 0037413961 scopus 로고    scopus 로고
    • Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, U.S. Armed Forces, 1998-2000
    • Lange JL, Lesikar SE, Brundage JF, Rubertone MV. Comprehensive systematic surveillance for adverse effects of anthrax vaccine adsorbed, U.S. Armed Forces, 1998-2000. Vaccine. 2003;21:1620-1628.
    • (2003) Vaccine , vol.21 , pp. 1620-1628
    • Lange, J.L.1    Lesikar, S.E.2    Brundage, J.F.3    Rubertone, M.V.4
  • 19
    • 5444232404 scopus 로고    scopus 로고
    • Disability among U.S. Army personnel vaccinated against anthrax
    • Sulsky SI, Grabenstein JD, Delbos RG. Disability among U.S. Army personnel vaccinated against anthrax. J Occup Environ Med. 2004;46:1065-1075.
    • (2004) J Occup Environ Med , vol.46 , pp. 1065-1075
    • Sulsky, S.I.1    Grabenstein, J.D.2    Delbos, R.G.3
  • 20
    • 0037181460 scopus 로고    scopus 로고
    • Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among U.S. Army women
    • Wiesen AR, Littell CT. Relationship between prepregnancy anthrax vaccination and pregnancy and birth outcomes among U.S. Army women. JAMA. 2002;287:1556-1560.
    • (2002) JAMA , vol.287 , pp. 1556-1560
    • Wiesen, A.R.1    Littell, C.T.2
  • 21
    • 13544267639 scopus 로고    scopus 로고
    • The anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member
    • Available at
    • Catherino WH, Levi A, Kao T-C, Leondires MP, McKeeby J, Segars JH. The anthrax vaccine does not affect semen parameters, embryo quality, or pregnancy outcome in couples with a vaccinated male military service member. Fertility Sterility 2005;83:480-483. Available at www.vaccines.mil/documents/library/ Catherino_Anthrax_Vaccine_2005.pdf.
    • (2005) Fertility Sterility , vol.83 , pp. 480-483
    • Catherino, W.H.1    Levi, A.2    Kao, T.-C.3    Leondires, M.P.4    McKeeby, J.5    Segars, J.H.6
  • 22
    • 0028177434 scopus 로고
    • The Vaccine Adverse Event Reporting System (VAERS)
    • Chen RT, Rastogi SC, Mullen JR, et al. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994;12:542-550.
    • (1994) Vaccine , vol.12 , pp. 542-550
    • Chen, R.T.1    Rastogi, S.C.2    Mullen, J.R.3
  • 23
    • 0029563036 scopus 로고
    • The reporting sensitivities of two passive surveillance systems for vaccine adverse events
    • Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Pub Health. 1995;85:1706-1709.
    • (1995) Am J Pub Health , vol.85 , pp. 1706-1709
    • Rosenthal, S.1    Chen, R.2
  • 24
    • 0036001099 scopus 로고    scopus 로고
    • Safety of anthrax vaccine: A review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    • Sever JL, Brenner AI, Gale AD, Lyle JM, Moulton LH, West DJ. Safety of anthrax vaccine: a review by the Anthrax Vaccine Expert Committee (AVEC) of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepid Drug Saf. 2002;11:189-202.
    • (2002) Pharmacoepid Drug Saf , vol.11 , pp. 189-202
    • Sever, J.L.1    Brenner, A.I.2    Gale, A.D.3    Lyle, J.M.4    Moulton, L.H.5    West, D.J.6
  • 25
    • 10844237302 scopus 로고    scopus 로고
    • Safety of anthrax vaccine: An expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS)
    • Sever JL, Brenner AI, Gale AD, et al. Safety of anthrax vaccine: an expanded review and evaluation of adverse events reported to the Vaccine Adverse Event Reporting System (VAERS). Pharmacoepid Drug Saf. 2004;13:825-840.
    • (2004) Pharmacoepid Drug Saf , vol.13 , pp. 825-840
    • Sever, J.L.1    Brenner, A.I.2    Gale, A.D.3
  • 26
    • 33745289069 scopus 로고    scopus 로고
    • Military hospitalizations among deployed US service members following anthrax vaccination, 1998-2001
    • Wells TS, Sato PA, Smith TC, Wang LZ, Reed RJ, Ryan MAK. Military hospitalizations among deployed US service members following anthrax vaccination, 1998-2001. Human Vaccines. 2006;2:54-59.
    • (2006) Human Vaccines , vol.2 , pp. 54-59
    • Wells, T.S.1    Sato, P.A.2    Smith, T.C.3    Wang, L.Z.4    Reed, R.J.5    Ryan, M.A.K.6
  • 28
    • 1842861810 scopus 로고    scopus 로고
    • Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice
    • Matyas GR, Rao M, Pittman PR, et al. Detection of antibodies to squalene: III. Naturally occurring antibodies to squalene in humans and mice. J Immunol Methods. 2004;286:47-67.
    • (2004) J Immunol Methods , vol.286 , pp. 47-67
    • Matyas, G.R.1    Rao, M.2    Pittman, P.R.3
  • 31
    • 37349074352 scopus 로고    scopus 로고
    • Incident abnormal findings within 30 days of medical examinations, active components, U.S. Armed Forces, January 1998-October 2006
    • Available at
    • Incident abnormal findings within 30 days of medical examinations, active components, U.S. Armed Forces, January 1998-October 2006. MSMR. 2006;12:10-16. Available at http://amsa.army.mil/1MSMR/2006/v12no09. pdf#IncidentAbnormalFindings.
    • (2006) MSMR , vol.12 , pp. 10-16
  • 32
    • 37349121700 scopus 로고    scopus 로고
    • Relationships between abnormal findings during medical examinations and subsequent diagnoses of significant conditions, active components, U.S. Armed Forces, January 1998-October 2006. MSMR. 2007;13:2-6. Available at
    • Relationships between abnormal findings during medical examinations and subsequent diagnoses of significant conditions, active components, U.S. Armed Forces, January 1998-October 2006. MSMR. 2007;13:2-6. Available at http://amsa.army.mil/1MSMR/2007/v13_no01.pdf#Cover.


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.